<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation-group" /><meta name="keywords" content="Sandostatin LAR; Octreotide" /><meta name="IX" content="Sandostatin LAR; Octreotide" /><title>Depot preparation: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5810-depot-preparation.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5810-depot-preparation.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5810-depot-preparation.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP5179-malignant-disease-and-immunosuppression.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="PHP5728-sex-hormones-and-hormone-antagonists-in-malignant-disease.htm">8.3 Sex hormones and hormone antagonists in malignant disease</a> &gt; <a href="PHP5746-hormone-antagonists.htm">8.3.4 Hormone antagonists</a> &gt; <a href="PHP5801-somatostatin-analogues.htm">8.3.4.3 Somatostatin analogues</a> &gt; <a href="PHP5807-octreotide.htm">OCTREOTIDE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5804-lanreotide.htm" title="Previous: LANREOTIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5812-nutrition-and-blood.htm" title="Next: 9 Nutrition and blood">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a393049.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Other Miscellaneous Therapeutic Agents 92:92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/13510-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Octreotide</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: O &gt; Interactions of Octreotide</p></div></li></ul><ul><li><h3>British National Formulary (7)</h3></li><li><a href="PHP130-continuous-infusion-devices.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Continuous infusion devices</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="PHP5668-introna.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">IntronA®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.4 Other immunomodulating drugs &gt; Interferon alfa &gt; INTERFERON ALFA</p></div></li><li><a href="PHP5801-somatostatin-analogues.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.3.4.3 Somatostatin analogues</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.3 Sex hormones and hormone antagonists in malignant disease &gt; 8.3.4 Hormone antagonists</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22octreotide%22%22octreotide%22%22carcinoid+tumour%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13274-chronic-hypoglycaemia.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Chronic hypoglycaemia</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.4 Treatment of hypoglycaemia</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13278-octreotide.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">OCTREOTIDE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.4 Treatment of hypoglycaemia &gt; Chronic hypoglycaemia</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13279-sandostatin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sandostatin®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.4 Treatment of hypoglycaemia &gt; Chronic hypoglycaemia &gt; OCTREOTIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22octreotide%22%22octreotide%22%22carcinoid+tumour%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1213.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; O</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a591005.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0014s0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/o01-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; O</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/16932-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Growth Hormone and its Modulators &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06762.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; O &gt; OC</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-O3.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; O</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-O4.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Octreotide Acetate</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; O</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D271.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Octreotide</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; O</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>OCTREOTIDE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int584-octreotide.htm">Octreotide</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see under Dose</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="target-block: Somatostatin analogue cautions" href="PHP5801-somatostatin-analogues.htm#PHP5802">notes above</a>; monitor thyroid function on long-term therapy; <strong>interactions:</strong> Appendix 1 (octreotide)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">adjustment of maintenance dose of non-depot preparations may be necessary in patients with liver cirrhosis</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">possible effect on fetal growth; manufacturer advises use only if potential benefit outweighs risk and effective contraception required during treatment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">manufacturer advises avoid—present in milk in <em>animal</em> studies</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="sub-sub-section: Somatostatin analogues" href="PHP5801-somatostatin-analogues.htm">notes above</a>; also arrhythmias, bradycardia, dyspnoea, headache, dizziness, dehydration, alopecia, rash; hepatitis also reported</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Symptoms associated with carcinoid tumours with features of carcinoid syndrome, VIPomas, glucagonomas, <span class="cK">by subcutaneous injection</span>, initially 50 micrograms once or twice daily, gradually increased according to response to 200 micrograms 3 times daily (higher doses required exceptionally); maintenance doses variable; in carcinoid tumours discontinue after 1 week if no effect; if rapid response required, initial dose <span class="cK">by intravenous injection</span> (with ECG monitoring and after dilution to a concentration of 10–50% with sodium chloride 0.9% injection)</p></li> <li><p>Acromegaly, short-term treatment before pituitary surgery <em>or</em> long-term treatment in those inadequately controlled by other treatment <em>or</em> until radiotherapy becomes fully effective <span class="cK">by subcutaneous injection</span>, 100–200 micrograms 3 times daily; discontinue if no improvement within 3 months</p></li> <li><p>Prevention of complications following pancreatic surgery, consult product literature</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP5808-octreotide-non-proprietary.htm#PHP5808-octreotide-non-proprietary" title="Octreotide">Octreotide</a></li><li><a href="PHP5809-sandostatin.htm#PHP5809-sandostatin" title="Sandostatin®">Sandostatin®</a></li></ul><div id="PHP5810-depot-preparation" style="margin: 0 0 0 20px;"><h1 class="title">Depot preparation</h1><ul class="jT"><li><a href="PHP5811-sandostatin-lar.htm#PHP5811-sandostatin-lar" title="Sandostatin Lar®">Sandostatin Lar®</a></li></ul></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5804-lanreotide.htm">Previous: LANREOTIDE</a> | <a class="top" href="PHP5810-depot-preparation.htm#">Top</a> | <a accesskey="]" href="PHP5812-nutrition-and-blood.htm">Next: 9 Nutrition and blood</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>